It’s usually a treatment your doctor will try if other things, such as medications, cardioversion therapy, or catheter ablation, have not worked. Most people who have AFib will not need the maze ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Records from a university hospital in Japan suggested that ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

Subgroup analyses identified that OAC discontinuation was associated with higher thromboembolic risk in patients with ...

The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

Wright would need an ablation to stop the AFib and the flutter ... During an ablation, a cardiac electrophysiologist snakes a catheter through a vein or artery, usually in the groin or the ...

The global atrial fibrillation market is projected to witness robust growth over the next decade. In 2023, the market generated a substantial revenue of US$ 3,505.7 million and is estimated to achieve ...

Research finds adults under 70 with atrial fibrillation have 21% higher dementia risk, with onset cases showing a dramatic 36% increase in cognitive decline.

For people with atrial fibrillation (Afib or AF), stopping oral anticoagulation (OAC) after a "successful" catheter ablation left them exposed to increased risk, according to a Japanese hospital's ...